Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

IDH1 and IDH2 Mutations Confer An Adverse Effect In Patients With Acute Myeloid Leukemia Lacking The NPM1 Mutation

Shunichiro Yamaguchi, MD, Eisaku Iwanaga, MD, PhD, Kenji Tokunaga, MD, Tomoko Nanri, MD, PhD, Taizo Shimomura, MD, PhD, Hitoshi Suzushima, MD, PhD, Yutaka Okuno, MD, PhD, Hiroaki Mitsuya, MD, PhD, Norio Asou, MD, PhD

Blood (2013) 122 (21): 4977.

https://doi.org/10.1182/blood.V122.21.4977.4977

Published: 2013

Journal Articles

Crebbp HAT Domain Mutations Are Frequently Detected in Adult Acute Lymphoblastic Leukemia

Kenji Tokunaga, MD, Shunichiro Yamaguchi, MD, Eisaku Iwanaga, MD, PhD, Tomoko Nanri, MD, PhD, Taizo Shimomura, MD, PhD, Hitoshi Suzushima, MD, PhD, Mitsuya Hiroaki, MD, PhD, Norio Asou, MD, PhD

Blood (2012) 120 (21): 1419.

https://doi.org/10.1182/blood.V120.21.1419.1419

Published: 2012

Journal Articles

Prognostic Impact and Concurrent Genetic Alterations of CEBPA Double Mutations in Adults with Cytogenetically Intermediate-Risk Acute Myeloid Leukemia.

Shunichiro Yamaguchi, MD, Kenji Tokunaga, MD, Eisaku Iwanaga, MD, PhD, Tomoko Nanri, MD, PhD, Taizo Shimomura, MD, PhD, Hitoshi Suzushima, MD, PhD, Hiroaki Mitsuya, Norio Asou, MD, PhD

Blood (2012) 120 (21): 2538.

https://doi.org/10.1182/blood.V120.21.2538.2538

Published: 2012

Journal Articles

IDH2 Mutations Have An Unfavorable Impact in Elderly Patients with Acute Myeloid Leukemia

Shunichro Yamaguchi, MD, Eisaku Iwanaga, MD, Kenji Tokunaga, MD, Tomoko Nanri, MD, PhD, Hitoshi Suzushima, MD, PhD, Taizo Shimomura, MD, PhD, Hiroaki Mitsuya, MD, PhD, Norio Asou, MD, PhD

Blood (2011) 118 (21): 2519.

https://doi.org/10.1182/blood.V118.21.2519.2519

Published: 2011

Journal Articles

A JAK2-V617F Activating Mutation in Addition to C-KIT and FLT3 Mutations Is Associated with Clinical Outcome in Patients with t(8;21)(q22;q22;) Acute Myeloid Leukemia.

Tomoko Nanri, MD, PhD, Eisaku Iwanaga, MD, Naofumi Matsuno, MD, PhD, Toshiro Kawakita, MD, Hitoshi Suzushima, MD, PhD, Fumio Kawano, MD, PhD, Hiroaki Mitsuya, MD, PhD, Norio Asou, MD, PhD

Blood (2007) 110 (11): 3492.

https://doi.org/10.1182/blood.V110.11.3492.3492

Published: 2007

NARROW

IDH1 and IDH2 Mutations Confer An Adverse Effect In Patients With Acute Myeloid Leukemia Lacking The NPM1 Mutation

Crebbp HAT Domain Mutations Are Frequently Detected in Adult Acute Lymphoblastic Leukemia

Prognostic Impact and Concurrent Genetic Alterations of CEBPA Double Mutations in Adults with Cytogenetically Intermediate-Risk Acute Myeloid Leukemia.

IDH2 Mutations Have An Unfavorable Impact in Elderly Patients with Acute Myeloid Leukemia

A JAK2-V617F Activating Mutation in Addition to C-KIT and FLT3 Mutations Is Associated with Clinical Outcome in Patients with t(8;21)(q22;q22;) Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

IDH1 and IDH2 Mutations Confer An Adverse Effect In Patients With Acute Myeloid Leukemia Lacking The NPM1 Mutation

Crebbp HAT Domain Mutations Are Frequently Detected in Adult Acute Lymphoblastic Leukemia

Prognostic Impact and Concurrent Genetic Alterations of CEBPA Double Mutations in Adults with Cytogenetically Intermediate-Risk Acute Myeloid Leukemia.

IDH2 Mutations Have An Unfavorable Impact in Elderly Patients with Acute Myeloid Leukemia

A JAK2-V617F Activating Mutation in Addition to C-KIT and FLT3 Mutations Is Associated with Clinical Outcome in Patients with t(8;21)(q22;q22;) Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only